Monthly Archives: November 2026

Tirzepatide Research: Specs, Purity & Lab Sourcing Guide

Tirzepatide is a long-acting, acylated dual receptor agonist peptide that co-activates the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R); in pharmaceutical development it was the first molecule approved by the FDA as a dual GIP/GLP-1 agonist, while catalog material sold under research labels is a lyophilized peptide reagent used for receptor-signaling […]

Semaglutide Research: Vial Specs, Purity Tests & CoA Guide

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist peptide, a 31-residue acylated analog of human GLP-1 developed by Novo Nordisk for pharmaceutical development programs; in research catalogs it is handled as a lyophilized peptide reagent for in vitro and analytical studies of receptor signaling, stability and assay development. Its chemical identity is fixed: CAS […]

CJC-1295 No DAC Research Profile: Identity, Mechanism & QC

CJC-1295 No DAC, also called modified GRF(1-29) or mod GRF 1-29, is a synthetic GHRH-receptor agonist modeled on the first 29 amino acids of human growth hormone-releasing hormone, with amino-acid substitutions designed to slow enzymatic cleavage. It stimulates the anterior pituitary to release endogenous growth hormone through the GHRH receptor (GHRHR) rather than through the […]

GHRP-6 Acetate Research: Discovery, Mechanism & Safety Notes

GHRP-6 acetate is a synthetic hexapeptide growth hormone secretagogue that activates the ghrelin receptor GHS-R1a to stimulate pulsatile growth hormone release from the anterior pituitary. Historically it was the first in vivo-active member of the growth hormone-releasing peptide (GHRP) family, synthesized by modifying met-enkephalin-like structures during the Bowers laboratory program of the 1980s. Its reference […]

GHRP-2 Acetate Research Guide: Mechanism, Evidence & Lab QC

GHRP-2 acetate is a synthetic hexapeptide growth hormone secretagogue, classified as an agonist of the ghrelin receptor GHS-R1a (growth hormone secretagogue receptor type 1a). It triggers pulsatile growth hormone (GH) release from anterior pituitary somatotrophs through a pathway distinct from natural growth hormone-releasing hormone (GHRH). Developed from the same peptide program that produced the GHRP […]